Search

everythinglearnresearchcommunity

for

Search:↓

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Finasteride and minoxidil together promote hair growth better than either alone.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Treat pattern hair loss with finasteride and topical minoxidil.

Hair transplantation can help transgender patients affirm their gender identity.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Antiandrogen therapy helps treat genetic hair loss.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

New hair loss treatments may include topical medications, injections, and improved transplant methods.